| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |